Kleo in collaboration with Korean company
New Haven biotech Kleo Pharmaceuticals is collaborating with a South Korean company to advance a potential drug targeting COVID-19. The Science Park-based startup said it...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
New Haven biotech Kleo Pharmaceuticals is collaborating with a South Korean company to advance a potential drug targeting COVID-19. The Science Park-based startup said it...
UConn researcher Jinbo Bi is using machine learning to better understand the genetic basis for substance use disorder. One of the challenges for researchers studying...
Why are men are 1.7 times more likely to die from the COVID-19 virus than women? Yale immunobiologist Akiko Iwasaki is studying the disparate immune responses...
The University of Connecticut maintains its headquarters upstate, but its brand is quickly growing in the state’s southwestern corner. University officials are intent on expanding...
Sema4 has named William K. Oh, M.D., to the newly established senior leadership position of Chief Medical Science Officer. Dr. Oh, who was previously Chair of...
Thetis Pharmaceuticals has completed a Pre-IND (Investigational New Drug) meeting with the FDA for its lead candidate, TP-317, a Resolvin E1 oral, small molecule therapy...
Immuno-oncology uses the body’s own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role because they use...
Marcum LLP has announced the winners of the 2020 Marcum Tech Top 40, an annual program recognizing the fastest growing technology and life sciences companies in...
New Haven biotech Arvinas is expanding its footprint at Yale’s Science Park by 10,000 square feet to make room for a wave of new hires....
Catalyst Clinical Research is a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry through two established solutions: Catalyst Flex...